These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2098546)

  • 1. Stereoselective acyl glucuronidation and glucosidation of pranoprofen, a 2-arylpropionic acid derivative, in mice in vivo.
    Arima N
    J Pharmacobiodyn; 1990 Dec; 13(12):733-8. PubMed ID: 2098546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl glucuronidation and glucosidation of pranoprofen, a 2-arylpropionic acid derivative, in mouse liver and kidney homogenates.
    Arima N
    J Pharmacobiodyn; 1990 Dec; 13(12):724-32. PubMed ID: 2098545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent shift in acyl glucuronidation and glucosidation of pranoprofen, a 2-arylpropionic acid derivative, in mice in vivo.
    Arima N; Kato Y
    J Pharmacobiodyn; 1990 Dec; 13(12):719-23. PubMed ID: 2098544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits.
    Nomura T; Imai T; Otagiri M
    Biol Pharm Bull; 1993 Mar; 16(3):298-303. PubMed ID: 8364476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in absorption, metabolism and excretion of pranoprofen, a 2-arylpropionic acid derivative, in experimental animals.
    Arima N; Kato Y
    J Pharmacobiodyn; 1990 Dec; 13(12):739-44. PubMed ID: 2098547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiospecific disposition of pranoprofen in beagle dogs and rats.
    Imai T; Nomura T; Aso M; Otagiri M
    Chirality; 2003 May; 15(4):312-7. PubMed ID: 12666237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probenecid-induced changes in the clearance of pranoprofen enantiomers.
    Imai T; Nomura T; Otagiri M
    Chirality; 2003 May; 15(4):318-23. PubMed ID: 12666238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of interaction of pranoprofen with human serum albumin: binding properties of enantiomers and metabolite.
    Nomura T; Sakamoto K; Imai T; Otagiri M
    J Pharmacobiodyn; 1992 Oct; 15(10):589-96. PubMed ID: 1494108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clofibric acid on the biliary excretion of benoxaprofen glucuronide and taurine conjugate in rats.
    Okada K; Kanoh H; Mohri K
    Pharmazie; 2011 Oct; 66(10):777-83. PubMed ID: 22026160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between glucuronidation and covalent adducts formation with proteins of nonsteroidal anti-inflammatory drugs.
    Shimada H; Kobayashi Y; Tanahashi S; Kawase A; Ogiso T; Iwaki M
    Eur J Pharm Sci; 2018 Jan; 112():132-138. PubMed ID: 29174986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of glycine conjugate and (-)-(R)-enantiomer from (+)-(S)-2-phenylpropionic acid suggesting the formation of the CoA thioester intermediate of (+)-(S)-enantiomer in dogs.
    Tanaka Y; Shimomura Y; Hirota T; Nozaki A; Ebata M; Takasaki W; Shigehara E; Hayashi R; Caldwell J
    Chirality; 1992; 4(6):342-8. PubMed ID: 1449948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of the phase II metabolites of the non steroidal anti-inflammatory drug etodolac in human urine.
    Berendes U; Blaschke G
    Enantiomer; 1996; 1(4-6):415-22. PubMed ID: 9676278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric composition analysis of pranoprofen in equine plasma and urine by chiral liquid chromatography-tandem mass spectrometry in selected reaction monitoring mode.
    Yu J; Han KS; Lee G; Paik MJ; Kim KR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3249-54. PubMed ID: 21036111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures to characterize in vivo and in vitro enantioselective glucuronidation properly: studies with benoxaprofen glucuronides.
    Spahn H; Iwakawa S; Lin ET; Benet LZ
    Pharm Res; 1989 Feb; 6(2):125-32. PubMed ID: 2762212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
    Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of pranoprofen gel for percutaneous administration.
    Choi JS; Shin SC
    Drug Dev Ind Pharm; 2007 Jan; 33(1):19-26. PubMed ID: 17192247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.
    Patel M; Tang BK; Grant DM; Kalow W
    Pharmacogenetics; 1995 Oct; 5(5):287-97. PubMed ID: 8563769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analgesic effect of topically applied pranoprofen-gel].
    Terasawa M; Yakushiji T; Iwahisa Y; Imayoshi T; Maruyama Y
    Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):433-40. PubMed ID: 3879232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation and covalent protein binding of benoxaprofen and flunoxaprofen in sandwich-cultured rat and human hepatocytes.
    Dong JQ; Smith PC
    Drug Metab Dispos; 2009 Dec; 37(12):2314-22. PubMed ID: 19773537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies on chiral inversion and amino acid conjugation of 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid in rats and dogs.
    Konishi T; Nishikawa H; Kitamura S; Tatsumi K
    Drug Metab Dispos; 1999 Jan; 27(1):158-60. PubMed ID: 9884325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.